Pfizer-BioNTech
COVID-19 vaccines: Differences, costs, and challenges

The COVID-19 pandemic saw the fastest development of a vaccine ever, with a number of research collaborations making this feat possible. But many challenges also remain

Vaccine rollout battle: First past the post may win major market share

India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people

Russia, UK, COVID vaccines UK and Russia announce start of COVID-19 vaccinations from next week

Both Russia’s Sputnik V and the UK’s Pfizer-BioNTech-produced vaccines are reported to be more than 95% effective in their final trials

    × To Subscribe